Moderna says its Covid-19 vaccine protective, safe in young children
A panel of FDA advisers will vote on Tuesday whether to authorize rival Pfizer and BioNTech's Covid-19 vaccine for use in children aged five to 11 years
A panel of FDA advisers will vote on Tuesday whether to authorize rival Pfizer and BioNTech's Covid-19 vaccine for use in children aged five to 11 years